APA aipamena

Ross, A., Donachie, P., Sallam, A., Stratton, I., Mohamed, Q., Scanlon, P., . . . Johnston, R. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

Chicago Style aipamena

Ross, A., P. Donachie, A. Sallam, I. Stratton, Q. Mohamed, P. Scanlon, J. Kirkpatrick, and R. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.

MLA aipamena

Ross, A., et al. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.